Snowflake results likely to show ‘resilient’ demand, pending acceleration: Jefferies (SNOW:NYSE)May 26, 2026
Share Facebook Twitter LinkedIn Pinterest Email Viridian Therapeutics GAAP EPS of -$1.09 beats by $0.08, revenue of $0.07M misses by $0.03M
Snowflake results likely to show ‘resilient’ demand, pending acceleration: Jefferies (SNOW:NYSE)May 26, 2026